Iran War Hype, Gold, and the Fed’s Debt Bubble

"Massive Culling" Imminent For Alt Managers, Soros Fund CEO Warns Authored by Lance Roberts via RealInvestmentAdvice.com, Dawn Fitzpatrick says overallocated LPs, frozen distributions, and mounting margin-call risk are converging into a sector-wide shakeout. Such will eventually separate survivors from the casualties. I used Claude to source data on private credit and equity funds, sources disclosed at the end. In July 2024, I penned an article entitled “Private Equity: Why Am I So Lucky,” which began with: “Lately, I have been getting many questions about investing in private equity. Such is common during raging bull markets, as individuals seek higher rates...

US Says (New) Ayatollah Wounded, Disfigured - While Other Iranian Leaders Defiantly March In Tehran As Bombs Fall Summary: Pentagon has just confirms two additional deaths in Thursday's downing of a KC-135 refueling tanker aircraft over Western Iraq: all six US crewmembers are deceased. Trump and the Pentagon claim the US and Israel are "totally destroying" Iran as the war enters day 14, with Trump warning Tehran to "watch what happens" and "I am killing them" and "what a great honor it is to" Iran’s new Supreme Leader Mojtaba Khamenei is reportedly alive...

Lilly Slides After New Obesity Pill Prescription Data Disappoints Wall Street Shares of Eli Lilly & Co. fell in New York premarket trading after new industry prescription data for the drugmaker's blockbuster obesity shot Zepbound and recently approved oral weight-loss pill Foundayo disappointed Wall Street analysts. Foundayo generated 3,707 prescriptions in its second week, according to new prescription-tracking data from IQVIA cited by RBC Capital Markets analysts. That compares with 18,410 prescriptions for Novo's oral version of Wegovy during its second week after launch, suggesting Lilly's weight-loss drugs are falling behind...